DR. JASON MICHAEL HERNDON M.D. NPI 1871856302

NPI Details

DR. Jason Michael Herndon, M.D. is a pain medicine anesthesiology in Manchester, TN with 14 years of experience. The provider is an anesthesiologist who provides a high level of care, either as a primary physician or consultant, for patients experiencing problems with acute, chronic and/or cancer pain in both hospital and ambulatory settings. Patient care needs are also coordinated with other specialists. DR. Jason Michael Herndon, M.D. NPI is 1871856302. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEHARRY MEDICAL COLLEGE SCHOOL OF MEDICINE
Graduation Year:2012

The provider's business location address is:

2345 MURFREESBORO HWY
MANCHESTER, TN
ZIP 37355-206
Phone: (931) 728-5607

The NPI 1871856302 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Testing for presence of drug, by chemistry analyzers (HCPCS:80307)
• Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml (HCPCS:Q9966)
• Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection of lower or sacral spine facet joint using imaging guidance, single level (HCPCS:64493)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0483)
• Injection of lower or sacral spine facet joint using imaging guidance, second level (HCPCS:64494)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
• Injection of substance into lower spine canal using imaging guidance (HCPCS:62323)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64635)
• Aspiration and/or injection of fluid large joint using ultrasound guidance (HCPCS:20611)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64636)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level (HCPCS:64484)
• Injection of upper or middle spine facet joint using imaging guidance, single level (HCPCS:64490)
• Injection of upper or middle spine facet joint using imaging guidance, second level (HCPCS:64491)
• Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance (HCPCS:27096)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• Insertion of spinal neurostimulator electrode array through skin (HCPCS:63650)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64633)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64634)
• Fluoroscopic guidance for needle placement (HCPCS:77002)
• Injection of substance into middle or upper spine canal using imaging guidance (HCPCS:62321)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0482)
• Injection, cefazolin sodium, 500 mg (HCPCS:J0690)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)

The enumeration date for this NPI number is 6/19/2012 and was last updated on 8/11/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.